AnaptysBio, Inc.ANABNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P8
Near historical low
vs 2Y Ago
-0.3x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -17.01% |
| 2024 | 17.35% |
| 2023 | 57.24% |
| 2022 | -9.85% |
| 2021 | 23.08% |
| 2020 | -19.44% |
| 2019 | 76.46% |
| 2018 | 81.93% |
| 2017 | 36.80% |
| 2016 | 30.72% |